135 related articles for article (PubMed ID: 30324116)
1. Induction of Specific Humoral Immune Response in Mice against a
Gholami M; Salimi Chirani A; Falak R; Moshiri M; Razavi S; Irajian G
Rep Biochem Mol Biol; 2018 Oct; 7(1):38-44. PubMed ID: 30324116
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice.
Gholami M; Chirani AS; Razavi S; Falak R; Irajian G
Lett Appl Microbiol; 2017 Nov; 65(5):439-445. PubMed ID: 28857243
[TBL] [Abstract][Full Text] [Related]
3. Passive immunization with anti- chimeric protein PilQ/PilA -DSL region IgY does not protect against mortality associated with Pseudomonas aeruginosa sepsis in a rabbit model.
Zamani K; Irajian G; Zahedi Bialvaei A; Zahraei Salehi T; Khormali M; Vosough A; Masjedian Jazi F
Mol Immunol; 2022 Jan; 141():258-264. PubMed ID: 34896925
[TBL] [Abstract][Full Text] [Related]
4. Construction, expression, purification and characterization of secretin domain of PilQ and triple PilA-related disulfide loop peptides fusion protein from
Faezi S; Bahrmand AR; Siadat SD; Nikokar I; Sardari S; Mahdavi M
Iran J Basic Med Sci; 2017 May; 20(5):458-466. PubMed ID: 28656079
[TBL] [Abstract][Full Text] [Related]
5. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Anti-Adhesive Vaccine Against
Faezi S; Bahrmand AR; Mahdavi M; Siadat SD; Nikokar I; Sardari S
Int J Mol Cell Med; 2017; 6(2):96-108. PubMed ID: 28890886
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection.
Banadkoki AZ; Keshavarzmehr M; Afshar Z; Aleyasin N; Fatemi MJ; Behrouz B; Hashemi FB
Biologicals; 2016 Sep; 44(5):367-73. PubMed ID: 27427517
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody directed to the PilQ -PilA DSL region in Pseudomonas aeruginosa improves survival of infected mice with antibiotic combination.
Zahedi Bialvaei A; Razavi S; Notash Haghighat F; Hemmati A; Akhavan MM; Jeddi-Tehrani M; Irajian G
Microb Pathog; 2021 Sep; 158():105060. PubMed ID: 34153421
[TBL] [Abstract][Full Text] [Related]
10. Active Immunization with Recombinant PilA protein Protects Against Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model.
Korpi F; Irajian G; Mahadavi M; Motamedifar M; Mousavi M; Laghaei P; Raei N; Behrouz B
J Microbiol Biotechnol; 2015 Sep; ():. PubMed ID: 26387817
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
12. A trivalent vaccine consisting of "flagellin A+B and pilin" protects against Pseudomonas aeruginosa infection in a murine burn model.
Hashemi FB; Behrouz B; Irajian G; Laghaei P; Korpi F; Fatemi MJ
Microb Pathog; 2020 Jan; 138():103697. PubMed ID: 31465785
[TBL] [Abstract][Full Text] [Related]
13. Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization.
Ahmadbeigi Y; Chirani AS; Soleimani N; Mahdavi M; Goudarzi M
Mol Immunol; 2020 Aug; 124():70-82. PubMed ID: 32540517
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.
Westritschnig K; Hochreiter R; Wallner G; Firbas C; Schwameis M; Jilma B
Hum Vaccin Immunother; 2014; 10(1):170-83. PubMed ID: 24064511
[TBL] [Abstract][Full Text] [Related]
16. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
[TBL] [Abstract][Full Text] [Related]
17. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.
Zhang X; Yang F; Zou J; Wu W; Jing H; Gou Q; Li H; Gu J; Zou Q; Zhang J
Vaccine; 2018 Feb; 36(8):1047-1054. PubMed ID: 29406241
[TBL] [Abstract][Full Text] [Related]
18. Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by
Das S; Howlader DR; Zheng Q; Ratnakaram SSK; Whittier SK; Lu T; Keith JD; Picking WD; Birket SE; Picking WL
Front Immunol; 2020; 11():583008. PubMed ID: 33281815
[TBL] [Abstract][Full Text] [Related]
19. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
20. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
